Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride have similar risks of sexual dysfunction for treating androgenetic alopecia. Users experience varying side effects, indicating individual differences in drug reactions.

The user is experiencing hair loss, possibly due to androgenic alopecia or telogen effluvium, and is considering treatments like Minoxidil, Finasteride, or RU58841. They also mention potential iron deficiency and sleep deprivation as contributing factors.

The user experienced hair density loss after increasing finasteride dosage from 3x to 7x a week. It was suggested that this might be a temporary adjustment issue, and adding minoxidil could help.

The user is experiencing hair thinning and visible scalp at 18, seeking advice on whether it's genetic or a scalp condition. Suggested treatments include Minoxidil, finasteride, ketoconazole shampoo, and CBD oil with MCT.

A 44-year-old man has been using finasteride 1mg daily and minoxidil 5% foam for 19 months to address hair loss, with mixed results and continued shedding. Suggestions include trying oral minoxidil, microneedling, and possibly a hair transplant for better cosmetic density.

The user experienced significant hair regrowth using minoxidil, microneedling, and estrogen, leading to a need to tie their hair back. They attribute the success to estrogen suppressing testosterone, alongside their routine of minoxidil, microneedling, and supplements.

The conversation discusses hair loss treatments for a woman experiencing androgenetic alopecia and seborrheic dermatitis, with suggestions including low-dose oral minoxidil, dutasteride, and hormone replacement therapy. The user is seeking advice due to intolerance to spironolactone and topical minoxidil, and concerns about low testosterone and DHT levels.

Low testosterone and estradiol may contribute to hair loss, and blocking DHT without sufficient hormone levels might hinder regrowth. The discussion highlights the importance of hormone balance, with some considering supplements and lifestyle changes to support hair health.

Finasteride can increase estrogen levels, causing dizziness and nausea. Users discuss adjusting treatment and diet, and explore alternatives for hair loss management.

The conversation is about a user's positive hair regrowth results using oral Dutasteride (DUT) and topical Minoxidil (MIN), with occasional derma rolling. The user experienced initial shedding but saw improvement after 8 months, and others discussed the use of Finasteride (FIN) and Tretinoin to enhance results.

Switching from finasteride to dutasteride can cause significant hair shedding if done abruptly. It's recommended to overlap both treatments and gradually taper off finasteride to minimize shedding.

The user experienced significant hair regrowth by using a combination of finasteride, oral minoxidil, and later switching to dutasteride. They initially started with finasteride and topical minoxidil, then moved to oral minoxidil and eventually transitioned from finasteride to dutasteride, which they found more effective.

A 34-year-old has been using finasteride for 18 months and minoxidil for 3 months, along with ketoconazole shampoo, supplements, and microneedling, to address hair loss. They report stabilized hair loss, thicker hair in previously miniaturized areas, and new hair growth along the hairline.

A user shared their 5-month progress using a topical treatment with finasteride, minoxidil, and retinoic acid, noting some hair growth but also shedding. Another user encouraged them, sharing their own experience of gradual improvement over 12 months and advising patience.

Scalp massages and natural methods alone are ineffective for treating hair loss. Effective treatments include using minoxidil and finasteride, with scalp massages as a supplementary aid.

Transplanted hairs are thinning after switching from topical to oral minoxidil, with increased shedding and miniaturization. The user is considering reintroducing topical minoxidil and has started using ketoconazole shampoo.

A 30-year-old male experienced hair shedding while using Minoxidil and Finasteride, with concerns about whether this is a normal shedding phase. Despite drastic hair loss, he continues the treatment, hoping for regrowth, and receives advice to maintain the regimen and consider lifestyle changes.

The user is considering postponing a scheduled hair transplant to see if finasteride and minoxidil treatments improve hair growth. Another user suggests waiting several months to assess the effectiveness of the medications before deciding on surgery.

The user shared their successful hair regrowth using oral finasteride, minoxidil foam, a custom topical solution, ketoconazole shampoo, and microneedling, resulting in significant improvement at the crown. However, they experienced hairline recession after switching to a topical solution with finasteride and minoxidil, raising concerns about its effectiveness.

A male experiencing crown and frontal baldness, along with overall hair thinning, is considering starting topical minoxidil and oral finasteride. He seeks advice on dosages, potential side effects, application tips, and whether to consult a dermatologist before beginning treatment.

The user is experiencing hair thinning and shedding despite no family history of male pattern baldness. They are considering starting treatments like Minoxidil or finasteride.

Cyclosporine A is discussed as a powerful hair growth stimulant, potentially more effective than minoxidil, but concerns about safety and side effects, including cancer risk, limit its use. The conversation highlights the need for further research and experimentation with topical application, despite its risks.

PP405 is expected to finish Phase 2 trials in late 2025, with potential market availability around 2028-2029 if all goes well. Current treatments like finasteride and minoxidil are still popular, while new options like KX-826 and Breezula are anticipated soon.

The user is experiencing positive hair regrowth after four months using a topical serum containing 0.3% finasteride and 6% minoxidil, specifically from the brand Hims. They apply the serum mainly to the hairline and have not observed any side effects.

GT-20029 is discussed as a potential hair loss treatment, with concerns about its safety and systemic absorption compared to finasteride. Users express skepticism about its effectiveness and safety, noting that it may not surpass existing treatments like finasteride and minoxidil.

Increased Malassezia and Cutibacterium in the scalp microbiome are linked to higher sebum production and inflammation in androgenetic alopecia (AGA). Treatments include ciclopirox shampoo, benzoyl peroxide shampoo, clobetasol propionate, calcipotriol, minoxidil, finasteride, and dutasteride.

A user on 1mg finasteride for a year has low estradiol levels but no significant symptoms, and others suggest monitoring without immediate concern. Some users discuss potential effects of low estrogen, like low libido, but the user reports no erectile dysfunction.

A user shared their experience with three hair transplants, finasteride, and minoxidil to combat severe hair loss, achieving significant regrowth. They discussed the process, costs, and maintenance, emphasizing that transplanted hair is permanent and doesn't require ongoing medication.

Dutasteride may cause chronic infertility by reducing semen volume and motility, with concerns about irreversible prostate fibrosis. Users consider switching to finasteride or using treatments like minoxidil and microneedling, weighing hair preservation against fertility.

Microneedling alone can stimulate hair growth and enhance the effectiveness of minoxidil. Combining microneedling with minoxidil is more effective than using minoxidil alone.